Measuring the Score: LDTs 1 – Science 0
The ruling overturning the FDA’s new regulations covering LDTs is good news. But the growing anti-science bias could impact healthcare more.
The ruling overturning the FDA’s new regulations covering LDTs is good news. But the growing anti-science bias could impact healthcare more.
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Researchers have developed an AI tool that uses gut bacteria data to accurately diagnose complex regional pain syndrome (CRPS).
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
Nordic Bioscience's PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.